The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
The action aims to reduce the risk of liver cancers associated with infections caused by the Hepatitis B and Hepatitis C viruses and the risk of gastric cancers caused by Helicobacter pylori.
Gastric cancer associated with Helicobacter pylori infection show important gaps in incidence across the Union. Moreover, there is an acute need to address the risk of liver cancer associated with these specific infections.
Each of the three types of infectious agents will be addressed by specific approaches targeted to support vaccination in case of Hepatitis B virus and to drug treatment in case of Hepatitis C virus and Helicobacter pylori. Specific activities will be dedicated to the early detection of infections, the cornerstone strategy to reduce the risk of liver and gastric cancer caused by the three mentioned pathogens.
EXPECTED RESULTS AND IMPACT
Reduction of incidence of Hepatitis B infections and chronic diseases and reduction of Hepatitis C and Helicobacter pylori related liver and gastric cancers, respectively.
60%
Applicants can apply for a higher project funding rate (maximum 80%) if your project is of ‘exceptional utility’.
In order to be eligible for funding, the applicants (beneficiaries and affiliated entities) must:
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
emakrigiorgi@moh.gov.cy
(Publish Date: 29/10/2021-for internal use only)
Stefan DE KEERSMAECKER
Telephone: +32 2 298 46 80
Email: stefan.de-keersmaecker@ec.europa.eu
Darragh CASSIDY
Telephone: +32 2 298 39 78
Email: darragh.cassidy@ec.europa.eu